Asset Details
Do you wish to reserve the book?
Pre-treatment serum apolipoprotein E: a promising prognostic indicator for nasopharyngeal carcinoma
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Pre-treatment serum apolipoprotein E: a promising prognostic indicator for nasopharyngeal carcinoma
Do you wish to request the book?
Pre-treatment serum apolipoprotein E: a promising prognostic indicator for nasopharyngeal carcinoma
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Pre-treatment serum apolipoprotein E: a promising prognostic indicator for nasopharyngeal carcinoma
2025
Overview
Background and purpose
This preliminary study explores the prognostic value of pretreatment peripheral serum apolipoprotein E (ApoE) in patients with non-metastatic nasopharyngeal carcinoma (NPC).
Materials and methods
A retrospective collection of pretreatment indicators was conducted for 352 nasopharyngeal carcinoma patients between January 2016 and December 2020. Receiver operating characteristic curve analysis, univariate and multivariate Cox proportional hazards analysis were all utilized to assess the correlation between blood ApoE and overall survival (OS), progression-free survival (PFS), distant metastasis-free survival (DMFS) and local recurrence-free survival (LRFS).
Results
A higher baseline serum ApoE level (> 71.5 mg/L) was markedly associated with poorer OS (HR = 2.255, 95% CI 1.232–4.125,
P
= 0.008) and remained an independent prognostic factor in multivariate Cox regression analysis. Additionally, body mass index (BMI), body surface area (BSA), Epstein-Barr virus (EBV)DNA load, and high-density lipoprotein cholesterol (HDL-C) were also identified as independent predictors of nasopharyngeal carcinoma prognosis.
Conclusion
An elevated pretreatment serum ApoE level is indicative of a poorer prognosis for nasopharyngeal carcinoma patients and is independent of other known prognostic factors. These findings highlight the value of ApoE as a potential biomarker for risk stratification and personalized treatment in nasopharyngeal carcinoma.
Publisher
BioMed Central,BioMed Central Ltd,Springer Nature B.V,BMC
Subject
/ Aged
/ Cancer
/ Disease
/ Female
/ Humans
/ Lipids
/ Male
/ Medicine
/ Nasopharyngeal Carcinoma - blood
/ Nasopharyngeal Carcinoma - diagnosis
/ Nasopharyngeal Carcinoma - mortality
/ Nasopharyngeal Carcinoma - therapy
/ Nasopharyngeal Neoplasms - blood
/ Nasopharyngeal Neoplasms - mortality
/ Nasopharyngeal Neoplasms - therapy
/ Oncology
/ Surgery
/ Tumors
